Delivery Order SPE2DB22D3301-SPE2DB25FZ0MN
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 15, 2025, to supply Terbinafine HCL 250 mg tablets (30-count units) to the Defense Logistics Agency's Medical Supply Chain. This competitive, non-set-aside award carries a ceiling value of $19,915.11 under a firm fixed-price delivery order, with an ultimate completion date of September 16, 2025. The product will be performed and delivered from AmerisourceBergen's Conshohocken...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 10, 2025, for Terbinafine HCL 250 mg tablets in quantities of 30s. The contract is valued at $2,379.19 under firm fixed price terms with an ultimate completion date of September 11, 2025. This is a non-set-aside award issued as a child delivery order, leveraging AmerisourceBergen's existing Indefinite Delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract by the Defense Logistics Agency (DLA) on August 15, 2025, with a ceiling value of $4,073.84. The contract covers the supply of Terbinafine HCL 250 mg tablets in quantities of 30, with an ultimate completion date of August 18, 2025. This is a firm fixed price delivery order awarded without set-aside designation, indicating it was competitively awarded....
- AmerisourceBergen Drug Corp was awarded a firm fixed price delivery order by the Defense Logistics Agency on September 18, 2025, for Terbinafine HCL 250 mg tablets (90-count supply) with a ceiling value of $2,042.89. This competitively awarded delivery order, which carries no set-aside designation, is set to conclude by September 19, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The award represents a continuation of the company's extensive...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 30 tablets. This competitive, non-set-aside contract represents a firm fixed-price delivery order with a ceiling value of $3,909.34 and an ultimate completion date of September 25, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a child order, this award falls under...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets (30 count) with a contract ceiling value of $5,618.72. The award was issued on September 18, 2025, with an ultimate completion date of September 19, 2025, and represents a non-set-aside competitive award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 90 with a ceiling value of $2,139.57. This firm fixed-price delivery order, which is not set-aside, is set to be completed by August 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,994.33 to AmerisourceBergen Drug Corp for Terbinafine HCL 250 mg tablets (90-count) on August 22, 2025, with a completion date of August 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a pharmaceutical supply delivery under the Defense Logistics Agency's...
- The Defense Logistics Agency awarded a $1,801.47 delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Terbinafine HCl 250 mg tablets in quantities of 30. This firm fixed price contract, with an ultimate completion date of August 4, 2025, represents a child delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The award was not set aside for small business or other designated categories and will be performed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 90, valued at $1,118.65 under a firm fixed-price contract. This non-set-aside delivery order will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 11, 2025. As a child contract action, this award falls under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FZ0MNDelivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on September 4, 2025, for Terbinafine HCL 250 mg tablets (90-count units) valued at $1,168.72. The contract is a firm fixed price delivery order with a completion date of September 5, 2025, and carries no set-aside designation, indicating it was competitively awarded. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The SPE2DX contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen maintains an extensive portfolio of deliveries across multiple therapeutic domains, including specialty medications, vaccines, and medical devices. The company's federal contract awards demonstrate its capability to fulfill diverse medical supply needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible contract mechanisms supporting military medical readiness.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 9/4/25 |